This formulation places the complete 20 mg payload of tirzepatide into a single, clear 2 ml multi-dose vial — no reconstitution guesswork, no lyophilization delay. The solution is sterile, pH-adjusted, and supplied at a concentration of 10 mg/ml, allowing straightforward volumetric dosing for those who build protocols on the basis of decimal-point accuracy. Hilma Biocare synthesizes the molecule to a purity standard that makes it a credible variable in any GLP-1/GIP receptor study, and the liquid format ensures the investigator draws directly into the syringe without an extra preparation step. At steroideu.shop, this listing is maintained for the researcher who treats peptide acquisition as a supply-chain discipline: verified source, intact cold chain, minimal handling. Tirzepatide’s dual incretin architecture is the focal point; Hilma Biocare’s quality envelope simply ensures it reaches the bench unaltered. No exaggerated claims, no metabolic narrative — just the compound, cleanly delivered.